Gyre Therapeutics Inc (GYRE)

Net Change in Cash

$6.80M

TTM · Period ending: · USD

GYRE logo

GYRE Net Change in Cash

Latest reported$6.80M
GYRE TTM Net Change in Cash (-$28.22M → $6.80M)
High-resolution chart · PNG

GYRE net change in cash history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gyre Therapeutics Inc Net Change in Cash — Trailing twelve months (TTM) (USD)
Period endingNet Change in Cash (USD)
6,796,000
22,456,000
25,257,000
24,536,000
20,394,000
-14,740,000
-21,696,000
-10,213,000
-7,629,000
1,641,000
-8,202,000
-13,547,000
-68,204,000
-23,209,000
-3,896,684
-20,791,684
17,048,316
-32,951,684
13,987,000
34,234,000
14,348,000
12,680,000
14,991,000
1,905,000
41,875,000
45,290,000
-15,894,000
-13,030,000
-29,310,000
-101,651,000
11,458,000
19,742,000
8,987,000
106,859,000
4,208,000
1,656,000
21,055,000
-6,047,000
-18,832,000
-13,779,000
-66,865,000
-52,533,000
-27,334,000
-22,611,000
34,781,000
28,072,000
1,945,000
-16,032,000
-19,642,000
-24,820,000
-27,755,000
-16,463,000
-8,586,000
-18,807,000
-25,043,000
-52,339,000
-96,497,000
-50,169,000
-58,571,000
-55,258,000
-53,484,000
-103,113,000
81,945,000
137,570,000
175,707,000
198,945,000
32,707,000
-13,272,842
-18,446,644
-22,461,608
-2,201,092
9,630,391
21,780,312
10,286,633
11,658,729
5,357,520
-8,792,119
27,979,832
16,893,061
15,773,904
12,253,532
-18,531,454
-28,224,046
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.